ZOLADEX LA 10.8mg implant medication leaflet

L02AE03 goserelin • Antineoplastic and immunomodulating agents | Hormones and related agents | Gonadotropin releasing hormone analogues

Goserelin is a medication mainly used in the treatment of prostate cancer in men and breast cancer in women, as well as in some gynecological conditions such as endometriosis. It works by reducing the levels of certain hormones in the body, which helps slow down or stop the growth of cancer cells or abnormal tissue.

The medication is administered as a subcutaneous implant, usually once every few weeks or months, depending on your doctor's instructions. The treatment is closely monitored to assess effectiveness and adjust the dose if necessary.

Side effects may include hot flashes, sweating, decreased libido, mood changes, bone pain, or reactions at the implant site. In some cases, allergic reactions or changes in bone density may occur. Any unusual symptoms should be reported to your doctor.

Goserelin is an effective medication for controlling certain types of cancer and hormonal conditions, but it requires strict medical supervision. Follow the administration schedule and your doctor's instructions to achieve the best results and minimize risks.

General data about ZOLADEX LA 10.8mg

Substance: goserelin

Date of last drug list: 01-06-2025

Commercial code: W65082001

Concentration: 10.8mg

Pharmaceutical form: implant

Quantity: 1

Product type: original

Price: 640.34 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ASTRAZENECA UK LTD. - MAREA BRITANIE

Holder: ASTRAZENECA AB - SUEDIA

Number: 1018/2008/01

Shelf life: 3 years

Pharmaceutical forms available for goserelin

Concentrations available for goserelin

10.8mg, 3.6mg

Other substances similar to goserelin

Compensation lists for ZOLADEX LA 10.8mg ASTRAZENECA

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

640.34 RON

640.34 RON

0.00 RON